21 CFR 522.1260 - Lincomycin.
(a) Specifications. Each milliliter of solution contains lincomycin hydrochloride monohydrate equivalent to:
(1) 25, 50, 100, or 300 milligrams (mg) lincomycin.
(2) 25, 100, or 300 mg lincomycin.
(3) 300 mg lincomycin.
(4) 100 or 300 mg lincomycin.
(c) Special considerations. When common labeling for use of the drug in dogs, cats, and swine is included with the drug, all such uses are subject to the labeling requirements of § 201.105 of this chapter.
(d) Related tolerances. See § 556.360 of this chapter.
(e) Conditions of use. It is used for animals as follows:
(1) Dogs and cats -
(i) Amount. 5 mg per pound (/lb) of body weight twice daily or 10 mg/lb body weight once daily by intramuscular injection; 5 to 10 mg/lb body weight one or two times daily by slow intravenous injection.
(ii) Indications for use. Infections caused by Gram-positive organisms, particularly streptococci and staphylococci.
(iii) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
(2) Swine -
(i) Amount. 5 mg/lb body weight once daily by intramuscular injection for 3 to 7 days.
(ii) Indications for use. Treatment of infectious arthritis and mycoplasma pneumonia.
(iii) Limitations. Do not treat within 48 hours of slaughter.
Title 21 published on 2015-04-01
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR Part 522 after this date.